Today it was reported that the EVP, Comp. Animal Health Sales of Heska Corp (NASDAQ: HSKA), Rod Lippincott, exercised options to sell 2,805 HSKA shares at $18.13 a share, for a total transaction value of $291.7K.
Following Rod Lippincott’s last HSKA Sell transaction on May 31, 2017, the stock climbed by 2.3%. In addition to Rod Lippincott, one other HSKA executive reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
HSKA’s market cap is $756.7M and the company has a P/E ratio of 131.06. Currently, Heska Corp has an average volume of 18.33K.
Based on 4 analyst ratings, the analyst consensus is Strong Buy with an average price target of $110.25, reflecting a 10.0% upside.
The insider sentiment on Heska Corp has been negative according to 32 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. It operates through the Core Companion Animal Health; and Other Vaccines, and Pharmaceuticals and Products segments.
